At the Barcelona meeting, IAVI released its Research and Development Agenda 2002-2004 [IAVI.org/vaccinedev/agenda.htm]. The Agenda is a blueprint for activities in several key areas and encompasses issues ranging from pre-clinical development to large-scale manufacturing of a licensed vaccine.